Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Hypertriglyceridemia · Asthma · GRCE

Grace Therapeutics

Grace Therapeutics patent portfolio — 34 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA HQ
18 Employees
Public company Type
GRCE · NYSE Ticker
Company details
Status
Public
HQ
3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA
Employees
18
Programs
29
Drugs
37
Patents
34
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Grace Therapeutics patents

34 pharmaceutical patents indexed for Grace Therapeutics. 1 expire within 24 months.

Grace Therapeutics has 34 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

34 patents

Patent portfolio

  1. US 12414943

    Nimodipine parenteral administration

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12049487

    Universal chimeric antigen receptor T-cell preparation technique

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11840575

    Engineered immune cells targeting BCMA and their uses thereof

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11484501

    Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11478420

    Vaginal probiotic products and related processes

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11478424

    Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11291672

    Betamethasone oral spray formulation and method of use to treat ataxia

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11052029

    Cation compatible metal oxides and oral care compositions containing the metal oxides

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11000711

    Compositions for forming films having a desired degree of obscuration and methods of making and using the same

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10842737

    Vaginal probiotic products and related processes

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10835495

    Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10793543

    Selective C-KIT kinase inhibitor

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10660856

    Porous silica gel as a carrier for liquid technologies

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10525290

    Compositions for forming films having a desired degree of obscuration and methods of making and using the same

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10258567

    Vaginal probiotic products and related processes

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10189872

    Crystalline form of nicotinamide riboside

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8835505

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8829054

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8569448

    NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7981936

    Crystalline ACAT inhibitor

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7964612

    Therapeutic pyrazolyl thienopyridines

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7820398

    Immunosorbent blood tests for assessing paroxysmal cerebral discharges

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7696159

    Treatment for basal cell carcinoma

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7678918

    Intermediates for imidazonaphthyridines

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7622610

    Crystalline ACAT inhibitor

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7615230

    Method for decreasing sebum production

    Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7335773

    Intermediates for imidazonaphthyridines

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7053125

    Controlled dispersion of colloidal suspension by comb polymers

    Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 6896876

    High cleaning silica gel dental abrasive, dentifrices prepared therefrom, and a method for preparing the dental abrasive

    Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6585960

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6440397

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6426201

    &bgr;-glucan products and extraction processes from cereals

    Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6294155

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6239110

    Synthetic analogs of thrombospondin and therapeutic use thereof

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Grace Therapeutics have?

34 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Grace Therapeutics patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.